Overcoming Immunogenicity And Safety Assessment Challenges For Biologics And Biosimilars In Oncology
In Partnership with
Expert panelists discuss regulatory challenges, flexible approaches to assay selection, and applying scientific reasoning with guidelines to address immunogenicity and safety assessment challenges in oncology biologics and biosimilars.
In Partnership with